Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin

FEBS Letters

Volumn 587, Issue 1, 2013, Pages 37-43

  Lv, Mingyu ^a,b   Wang, Jiawen ^a   Zhu, Yingzi ^a   Wang, Xiaodan ^a   Zuo, Tao ^a   Liu, Donglai ^a   Zhang, Jingyao ^a   Wu, Jiaxin ^a   Zhang, Haihong ^a   Kong, Wei ^a   Yu, Xianghui ^a  

^a JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

HIV 1; Overexpression; Tetherin; Vpu

Indexed keywords

MEMBRANE PROTEIN; TETHERIN; UNCLASSIFIED DRUG; VPU PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DIMERIZATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; MUTANT; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VIRION; VIRUS RELEASE;

ANTIGENS, CD; FEASIBILITY STUDIES; GENETIC THERAPY; GLYCOSYLPHOSPHATIDYLINOSITOLS; GPI-LINKED PROTEINS; HEK293 CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MICROSCOPY, FLUORESCENCE; MUTANT PROTEINS; PROTEIN ENGINEERING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STABILITY; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; SEQUENCE DELETION; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRION; VIRUS RELEASE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871722806     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.11.022     Document Type: Article

References (34)

1. T. Zuo Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC J. Virol. 86 2012 5497 5507
2. S. Cen Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G J. Biol. Chem. 285 2010 16546 16552
3. R. Nathans, H. Cao, N. Sharova, A. Ali, M. Sharkey, R. Stranska, M. Stevenson, and T.M. Rana Small-molecule inhibition of HIV-1 Vif Nat. Biotechnol. 26 2008 1187 1192
4. S.J. Neil, T. Zang, and P.D. Bieniasz Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Nature 451 2008 425 430
5. N. Van Damme, D. Goff, C. Katsura, R.L. Jorgenson, R. Mitchell, M.C. Johnson, E.B. Stephens, and J. Guatelli The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein Cell Host Microbe 3 2008 245 252
6. S. Kupzig, V. Korolchuk, R. Rollason, A. Sugden, A. Wilde, and G. Banting Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology Traffic 4 2003 694 709
7. A. Hinz Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain Cell Host Microbe 7 2010 314 323
8. H.L. Schubert Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations Proc. Natl. Acad. Sci. USA 107 2010 17951 17956
9. H. Yang Structural insight into the mechanisms of enveloped virus tethering by tetherin Proc. Natl. Acad. Sci. USA 107 2010 18428 18432
10. M. Swiecki, S.M. Scheaffer, M. Allaire, D.H. Fremont, M. Colonna, and T.J. Brett Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release J. Biol. Chem. 286 2011 2987 2997
11. T. Goto, S.J. Kennel, M. Abe, M. Takishita, M. Kosaka, A. Solomon, and S. Saito A novel membrane antigen selectively expressed on terminally differentiated human B cells Blood 84 1994 1922 1930
12. T. Ohtomo Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells Biochem. Biophys. Res. Commun. 258 1999 583 591
13. A.J. Andrew, E. Miyagi, S. Kao, and K. Strebel The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu Retrovirology 6 2009 80
14. D. Perez-Caballero, T. Zang, A. Ebrahimi, M.W. McNatt, D.A. Gregory, M.C. Johnson, and P.D. Bieniasz Tetherin inhibits HIV-1 release by directly tethering virions to cells Cell 139 2009 499 511
15. T. Sakuma, A. Sakurai, and J. Yasuda Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses PLoS One 4 2009 e6934
16. M.W. McNatt, T. Zang, T. Hatziioannou, M. Bartlett, I.B. Fofana, W.E. Johnson, S.J. Neil, and P.D. Bieniasz Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants PLoS Pathog. 5 2009 e1000300
17. R.K. Gupta, S. Hue, T. Schaller, E. Verschoor, D. Pillay, and G.J. Towers Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion PLoS Pathog. 5 2009 e1000443
18. L. Rong The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu J. Virol. 83 2009 7536 7546
19. M. Lv, J. Wang, X. Wang, T. Zuo, Y. Zhu, W. Kong, and X. Yu Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity PLoS One 6 2011 e20890
20. M. Montal Vpu matchmakers as a therapeutic strategy for HIV infection PLoS Pathog. 5 2009 e1000246
21. M. Skasko HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions J. Biol. Chem. 287 2012 58 67
22. B. Mangeat, G. Gers-Huber, M. Lehmann, M. Zufferey, J. Luban, and V. Piguet HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation PLoS Pathog. 5 2009 e1000574
23. S.J. Neil, S.W. Eastman, N. Jouvenet, and P.D. Bieniasz HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane PLoS Pathog. 2 2006 e39
24. Y. Iwabu, H. Fujita, M. Kinomoto, K. Kaneko, Y. Ishizaka, Y. Tanaka, T. Sata, and K. Tokunaga HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes J. Biol. Chem. 284 2009 35060 35072
25. J. Hammonds, J.J. Wang, H. Yi, and P. Spearman Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane PLoS Pathog. 6 2010 e1000749
26. J.G. Magadan, and J.S. Bonifacino Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu J. Virol. 86 2012 757 772
27. M.H. Malim, and P.D. Bieniasz HIV Restriction Factors and Mechanisms of Evasion Cold Spring Harb. Perspect. Med. 2 2012 a006940
28. K. Kikawa, K. Nishida, A. Tanizawa, Y. Shigematsu, A. Nakai, M. Sudo, and T. Matsuyama Growth retardation as a long-term side-effect of alpha-interferon therapy Eur. J. Pediatr. 154 1995 591 592
29. M.R. Kraus, and K. Wilms Interferon alpha. Effect, indications, therapy monitoring and side-effects Internist (Berl) 41 2000 1399 1404
30. A. Andrew, and K. Strebel The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor? J. Interferon Cytokine Res. 31 2011 137 144
31. C. Jolly, N.J. Booth, and S.J. Neil Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells J. Virol. 84 2010 12185 12199
32. N. Casartelli, M. Sourisseau, J. Feldmann, F. Guivel-Benhassine, A. Mallet, A.G. Marcelin, J. Guatelli, and O. Schwartz Tetherin restricts productive HIV-1 cell-to-cell transmission PLoS Pathog. 6 2010 e1000955
33. J. Zhang, and C. Liang BST-2 diminishes HIV-1 infectivity J. Virol. 84 2010 12336 12343
34. A.A. Waheed, S.D. Ablan, F. Soheilian, K. Nagashima, A. Ono, C.P. Schaffner, and E.O. Freed Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence J. Virol. 82 2008 9776 9781